Author’s reply to: “concerns over: Efficacy and safety of 0.1% cyclosporine a cationic emulsion in the treatment of severe dry eye disease”

Leonardi A., Van Setten G., Amrane M., Ismail D., Garrigue J.-S., Figueiredo F.C., Baudouin C.

Affiliations

Department of Neuroscience, Ophthalmology Unit, University of Padua, Padua, Italy; St. Eriks Eye Hospital, Stockholm, Sweden; Santen SAS, Evry, France; Royal Victoria Infirmary, Newcastle University, Newcastle upon Tyne, United Kingdom; Quinze-Vingts National Ophthalmology Hospital, Paris, France; UPMC University, Vision Institute, INSERM UMRS968, CNRS UMR7210, Paris 6, Paris, France; University of Versailles Saint-Quentin en Yvelines, Versailles, France

Related Publications

Zhou L.; Shimizu H.; Togashi Y.; Kirihara T.; Yang Y.; Lam C.T.; Shimada H.; Tong L.

Arita R., Takeuchi G., Sasai K., Nakamura M., Akiba M.

Blautain, B.; Rabut, G.; Dupas, B.; Riancho, L.; Liang, H.; Luzu, J.: Labbé, A.; Garrigue J.-S.; Brignole-Baudouin, F.; Baudouin, C.; Kessal, K.